| Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia P Ganesan, TG Sagar, B Dubashi, R Rajendranath, K Kannan, S Cyriac, ... American journal of hematology 86 (6), 471-474, 2011 | 234 | 2011 |
| Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies RN Al‐Rohil, AJ Tarasen, JA Carlson, K Wang, A Johnson, R Yelensky, ... Cancer 122 (2), 249-257, 2016 | 82 | 2016 |
| Significantly reduced regulatory T cell population in patients with untreated multiple myeloma R Gupta, P Ganeshan, M Hakim, R Verma, A Sharma, L Kumar Leukemia research 35 (7), 874-878, 2011 | 68 | 2011 |
| Comprehensive evaluation of adherence to therapy, its associations, and its implications in patients with chronic myeloid leukemia receiving imatinib R Unnikrishnan, S Veeraiah, S Mani, R Rajendranath, S Rajaraman, ... Clinical Lymphoma Myeloma and Leukemia 16 (6), 366-371. e3, 2016 | 49 | 2016 |
| Chronic myeloid leukemia in India P Ganesan, L Kumar Journal of global oncology 3 (1), 64-71, 2017 | 48 | 2017 |
| Target-Based Therapeutic Matching in Early-Phase Clinical Trials in Patients with Advanced Colorectal Cancer and PIK3CA Mutations P Ganesan, F Janku, A Naing, DS Hong, AM Tsimberidou, GS Falchook, ... Molecular cancer therapeutics 12 (12), 2857-2863, 2013 | 48 | 2013 |
| Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents P Ganesan, S Moulder, JJ Lee, F Janku, V Valero, RG Zinner, A Naing, ... Molecular cancer therapeutics 13 (12), 3175-3184, 2014 | 44 | 2014 |
| Phase II study of interim PET–CT-guided response-adapted therapy in advanced Hodgkin's lymphoma P Ganesan, R Rajendranath, K Kannan, V Radhakrishnan, TS Ganesan, ... Annals of Oncology 26 (6), 1170-1174, 2015 | 42 | 2015 |
| Intravenous fosaprepitant for the prevention of chemotherapy‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial V Radhakrishnan, A Joshi, J Ramamoorthy, S Rajaraman, P Ganesan, ... Pediatric Blood & Cancer 66 (3), e27551, 2019 | 37 | 2019 |
| Hodgkin’s lymphoma—long-term outcome: an experience from a tertiary care cancer center in North India P Ganesan, L Kumar, V Raina, A Sharma, S Bakhshi, V Sreenivas, ... Annals of hematology 90, 1153-1160, 2011 | 36 | 2011 |
| Acute lymphoblastic leukemia: a single center experience with Berlin, Frankfurt, and Munster-95 protocol V Radhakrishnan, S Gupta, P Ganesan, R Rajendranath, TS Ganesan, ... Indian Journal of Medical and Paediatric Oncology 36 (04), 261-264, 2015 | 33 | 2015 |
| Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric … L Sandhya, N Devi Sreenivasan, L Goenka, B Dubashi, S Kayal, ... Journal of Clinical Oncology 41 (14), 2617-2627, 2023 | 30 | 2023 |
| Outcomes in lung cancer: 9-year experience from a tertiary cancer center in India AN Murali, V Radhakrishnan, TS Ganesan, R Rajendranath, P Ganesan, ... Journal of Global Oncology 3 (5), 459-468, 2017 | 30 | 2017 |
| High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country L Kumar, J Ghosh, P Ganessan, A Gupta, R Hariprasad, V Kochupillai Bone marrow transplantation 43 (6), 481-489, 2009 | 27 | 2009 |
| Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer P Ganesan, S Piha-Paul, A Naing, G Falchook, J Wheler, F Janku, ... Investigational new drugs 31, 1505-1513, 2013 | 25 | 2013 |
| Pediatric Hodgkin lymphoma treated at Cancer institute, Chennai, India: Long-term outcome V Radhakrishnan, M Dhanushkodi, TS Ganesan, P Ganesan, ... Journal of Global Oncology 3 (5), 545-554, 2017 | 23 | 2017 |
| Acute myeloid leukemia in children: experience from tertiary cancer centre in India V Radhakrishnan, C Thampy, P Ganesan, R Rajendranath, TS Ganesan, ... Indian Journal of Hematology and Blood Transfusion 32, 257-261, 2016 | 23 | 2016 |
| Nutritional profile of pediatric cancer patients at Cancer Institute, Chennai V Radhakrishnan, P Ganesan, R Rajendranath, TS Ganesan, TG Sagar Indian Journal of Cancer 52 (2), 207-209, 2015 | 23 | 2015 |
| Childhood aleukemic leukemia with hypercalcemia and bone lesions mimicking metabolic bone disease P Ganesan, S Thulkar, R Gupta, S Bakhshi Journal of Pediatric Endocrinology and Metabolism 22 (5), 463-468, 2009 | 20 | 2009 |
| Epidermal growth factor receptor P753S mutation in cutaneous squamous cell carcinoma responsive to cetuximab-based therapy P Ganesan, SM Ali, K Wang, GR Blumenschein, B Esmaeli, RA Wolff, ... Journal of Clinical Oncology 34 (5), e34-e37, 2016 | 19 | 2016 |
